Ricky Zhu

Vice President @ Boston Scientific

About

Over 20 years of sales and business development experience in the healthcare industry in Asia. Proven ability to lead cross-functional teams and multiple projects, delivering outstanding results by empowering others. P&L management experience. Specialties: Strategic planning, M&A project management, account management, communication in English and Chinese, customer relations, marketing and branding, sales management

Country

China

City

Huangpu District

Industry

Medical Device

Skill

Strategic Planning, Sales Management, Customer Relations, Strategy Development, Key Account Management, Team Leadership, P&L Responsibility, Investment Advisory, New Product Roll Out, Project Management, Strategy, Product Launch, Marketing Strategy, Marketing Management, Product Development, Market Analysis, Cross-functional Team Leadership, Management, Business Strategy, Business Development

Experience

Vice President

Boston Scientific

2026-3 - Present · 7 mos

Shanghai, China

Senior BU Director

Boston Scientific

2018-3 - Present · 8 yrs 7 mos

Shanghai City, China

CRM & NMD BU Head; Commercial leader for 2 Business Units (Cardiac Rhythm management & Neuromodulation)

Marketing Director

Abbott (Formerly St. Jude Medical)

2014-3 - 2018-2 · 4 yrs

Shanghai City, China

Oversee marketing, training and business development team in AF Division

Marketing Leader APAC

2013-6 - 2014-2 · 9 mos

Shanghai City, China

Strategic Marketing Manager

Tecan

2010-1 - 2013-5 · 3 yrs 5 mos

Shanghai

Driving strategy development, planning and execution for Tecan Asia. Define & execute Tecan’s alliance, partnering and investment strategies in the Chinese market Conduct market analysis, issuing the product required document for the new product concept

Regional Sales Manager

Johnson & Johnson Medical (China)

2001-7 - 2008-12 · 7 yrs 6 mos

Directed sales targeting, budgeting, and team development for Northern China region; responsible for regional revenue. Led a cross-functional team to turn around a shrinking performance in a $5m gain amidst high competition.